Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing education activity is provided by 
.
Educational Partner: 
Support Statement: This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Target Audience: The intended audience for this activity is physician assistants, nurse practitioners and other health care professionals involved in the treatment of patients with IBD.
Learning Objectives: Upon successful completion of this educational activity, participants should be better able to:
- Examine the pathophysiology of inflammatory bowel disease to better understand how specific therapies aid in the treatment of mild to severe disease.
- Describe various diagnostic modalities and assessment tools that may improve the early diagnosis of inflammatory bowel disease.
- Evaluate medical advances for patients with inflammatory bowel disease that may improve patient management and outcomes.
- Assess everyday challenges that may present to advanced practice clinicians, as well as interventions and solutions that have served to improve the overall outcome of these patients.
Co-Chairs:
Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine
Director, Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
David T. Rubin, MD, FACG, AGAF, FACP, FASGE
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
PA Reviewer:
Linda A. Giarraputo, PA-C
Nurse Reviewers:
Barbara A. Niedz, PhD, RN, CPHQ
Natalie Wilson, MS, RN
Accreditation: 
Vindico Medical Education, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation:
Vindico Medical Education will provide 1.5 contact hours for nurses.
There is no non-commercial support for this activity.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.
Physician Assistants: 
This program has been reviewed and is approved for a maximum of 1.50 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of 01/31/2018. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
Nurse Practitioners:
This activity is approved for 1.5 contact hour(s) of continuing education (which includes 0.5 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18012998. This activity was planned in accordance with AANP CE Standards and Policies.
This enduring material is approved for 1 year from the date of original release, January 31, 2018 to January 31, 2019.
How To Participate in this Activity and Obtain CE Credit:
To participate in this CE activity, you must read the objectives, answer the pretest questions, view the CE Content, and complete the CE posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 5 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue Credit Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.
Activity Co-Chairs report the following relationship(s):
Russell D. Cohen, MD, FACG, AGAF
Consulting Fee: AbbVie, Celgene, Entera Health, Hospira, Janssen (Johnson & Johnson / Centocor), Pfizer, Sandoz Biopharmaceuticals, Takeda, UCB
Speakers Bureau: AbbVie, Takeda
Contracted Research: Celgene, Janssen, Pfizer, Takeda
David T. Rubin, MD, FACG, AGAF, FACP, FASGE
Consulting Fee: AbbVie, Abgenomics, Allergan, Amgen, Celegene, Forward Pharma, Genentech/Roche, Janssen, Merck, Miraca Life Sciences, Napo Pharmaceuticals, Pfizer, Samsung Bioepis, Sandoz, Shire, Takeda
Contracted Research: AbbVie, Genentech/Roche, Janssen, Prometheus, Shire, Takeda, UCB
Reviewers report the following relationship(s):
Linda A. Giarrputo, PA-C
No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Natalie Wilson, MS, RN
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA-approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com.